Loading clinical trials...
Loading clinical trials...
Evaluation of Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation
Conditions
Interventions
Actigraph CP Insight Watch
Locations
1
United States
University of South Florida/ Tampa General Hospital
Tampa, Florida, United States
Start Date
September 1, 2023
Primary Completion Date
May 1, 2025
Completion Date
May 1, 2026
Last Updated
December 15, 2023
NCT05722340
NCT06572384
NCT04707781
NCT06122233
NCT04325217
NCT05285982
Lead Sponsor
University of South Florida
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions